Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 270,925 |
|
|||||
| News | - | ||||||
| Day High | 22.78 | Low High |
|||||
| Day Low | 22.05 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cullinan Therapeutics Inc | CGEM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.14 | -0.62% | 22.40 | 16:51:37 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 22.41 | 22.05 | 22.78 | 22.40 | 22.54 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,129 | 270,925 | US$ 22.49 | US$ 6,092,217 | - | 7.64 - 30.1886 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:36:02 | 2 | US$ 21.34 | USD |
Cullinan Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 966.39M | 43.07M | - | 0 | -153.16M | -3.56 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cullinan Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CGEM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 22.85 | 24.3094 | 21.79 | 22.86 | 626,895 | -0.45 | -1.97% |
| 1 Month | 27.30 | 28.19 | 21.79 | 23.90 | 627,666 | -4.90 | -17.95% |
| 3 Months | 16.87 | 30.1886 | 14.98 | 22.24 | 806,212 | 5.53 | 32.78% |
| 6 Months | 8.13 | 30.1886 | 7.64 | 19.64 | 576,539 | 14.27 | 175.52% |
| 1 Year | 12.40 | 30.1886 | 7.64 | 17.17 | 396,783 | 10.00 | 80.65% |
| 3 Years | 33.20 | 34.6859 | 7.30 | 15.83 | 305,141 | -10.80 | -32.53% |
| 5 Years | 42.00 | 59.85 | 7.30 | 18.28 | 302,997 | -19.60 | -46.67% |
Cullinan Therapeutics Description
| Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. |
